Skip to main content

Table 2 Knowledge of molecular diagnostics for MDR-TB comparing DTLCs and DACs

From: Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation

Molecular Technology Characteristic Sub Category All DTLCs DACs p - value
GeneXpertMTB/RIF Description. No. (%) Understands 37 (70) 22 (81) 15 (57) 0.11
Intermediate understanding 14 (26) 5 (19) 9 (35)
Does not understand 2 (4) 0 (0) 2 (8)
  Clinical application. No.(%) Understands 38 (72) 24 (89) 14 (54) 0.015
Intermediate understanding 13 (24) 3 (11) 10 (38)
Does not understand 2 (4) 0 (0) 2 (8)
  Result interpretation. No. (%) Understands 22 (42) 16 (59) 6 (23) 0.014
Intermediate understanding 15 (28) 7 (26) 8 (31)
Does not understand 16 (30) 4 (15) 12 (46)
GenotypeMTBDRplus Description. No. (%) Understands 10 (19) 8 (30) 2 (8) 0.12
Intermediate understanding 12 (23) 5 (19) 7 (27)
Does not understand 31 (58) 14 (51) 17 (65)
Clinical application. No. (%) Understands 9 (17) 8 (30) 1 (4) 0.36
Intermediate understanding 14 (26) 7 (26) 7 (27)
Does not understand 30 (57) 12 (44) 18 (69)
Result interpretation. No.(%) Understands 0 (0) 0 (0) 0 (0) 0.15
Intermediate understanding 5 (9) 1 (4) 4 (15)
Does not understand 48 (91) 26 (96) 22 (85)
  1. DTLC District tuberculosis and leprosy coordinator. DAC District AIDS coordinator